Discover 1,474 paid clinical trials in Kent, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,474
SLV-154 Treatment of Advanced Cancers
for
Advanced Cancer, Advanced Solid Tumor, Metastatic Cancer
Location: Tacoma WA, Seattle WA, Newport Beach CA, St Louis MO,
Sponsor: Solve Therapeutics
Sex: All
Age: 12+
Code: NCT06771219
Phase 1, Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
Location: Tacoma WA, Olympia WA, Las Vegas NV, Anaheim CA,
Sponsor: Shanghai Henlius Biotech
Sex: All
Age: 18+
Code: NCT06532006
Phase 3, Recruiting
Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer
for
Breast Cancer, Breast Cancer Metastatic,
Location: Tacoma WA, Dallas TX, Fort Wayne IN, Houston TX,
Sponsor: Incyclix Bio
Sex: All
Age: 18+
Code: NCT05735080
Phase 1, Phase 2, Recruiting
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
for
Paroxysmal Atrial Fibrillation
Location: Tacoma WA, Puyallup WA, Ventura CA, Aurora CO,
Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Sex: All
Age: 18+
Code: NCT06324201
Recruiting
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
for
Sepsis, Length of Stay, Mortality, Neurodevelopmental Delay
Location: Tacoma WA
Sponsor: University of Washington
Sex: All
Age: 0 - 2
Code: NCT06893939
Phase 2, Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
for
Atrial Fibrillation
Location: Tacoma WA, Sacramento CA, Stanford CA,
Sponsor: Johns Hopkins University
Sex: All
Age: 22 - 70+
Code: NCT05836987
Phase 3, Recruiting
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Tacoma WA, Seattle WA, Olympia WA, Salem OR, Spokane WA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
for
Diffuse Large B-Cell Lymphoma
Location: Tacoma WA, Olympia WA, Lubbock TX, Des Moines IA,
Sponsor: AstraZeneca
Sex: All
Age: 65 - 70+
Code: NCT05952024
Phase 2, Recruiting
Lysosomal Acid Lipase (LAL) Deficiency Registry
for
Lysosomal Acid Lipase Deficiency,
Location: Tacoma WA, Edmonton, Stanford CA, Phoenix AZ,
Sponsor: Alexion Pharmaceuticals, Inc.
Sex: All
Age: 0+
Code: NCT01633489
Recruiting
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
for
Non-small Cell Lung Cancer (NSCLC)
Location: Tacoma WA, Vancouver, Grand Junction CO, Los Angeles CA,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT07291037
Phase 3, Recruiting
Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer
for
Metastatic Colorectal Cancer (CRC)
Location: Tacoma WA, Vancouver, Spokane WA, Roseville CA,
Sponsor: Summit Therapeutics
Sex: All
Age: 18+
Code: NCT07228832
Phase 3, Recruiting
A Study of Surovatamig (AZD0486) Plus Rituximab in Previously Untreated Follicular Lymphoma Patients
for
Untreated Follicular Lymphoma
Location: Tacoma WA, Los Alamitos CA, Phoenix AZ, Winnipeg,